Latham & Watkins Advises Nevro Corp. on Acquisition of Vyrsa™ Technologies and ...

Retrieved on: 2023-12-09 21:05:42

Tags for this article:

Click the tags to see associated articles and topics

Latham & Watkins Advises Nevro Corp. on Acquisition of Vyrsa™ Technologies and .... View article details on hiswai:

Excerpt

(NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, has ...

Article found on: legaldesire.com